Aktis Oncology (AKTS)
Develops targeted radiopharmaceuticals for solid tumors using miniprotein radioconjugates.
$21.04
vs last close−1.07 (−4.84%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 50 days
EPS estimate
−$0.47
Revenue estimate
$3.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '24May '24Nov '24Dec '25Mar '26May '26Aug '26Nov '26
Reported−$0.19−$0.14−$0.04−$1.39−$18.19−$0.38−$0.44Pending
Estimate−$0.18−$0.12−$0.10−$0.11−$21.59−$0.31−$0.43−$0.47
Surprise−5.6%−16.7%+60.0%−1,163.6%+15.8%−22.6%−2.2%—
RevenueReportedEstimate
Feb '24May '24Nov '24Dec '25Mar '26May '26Aug '26Nov '26
Reported———$4.6M$1.9M$3.2M$3.4MPending
Estimate$8.4M$7.0M$9.3M$12.4M$3.3M$1.9M$2.7M$3.8M
Surprise———−62.9%−43.0%+67.2%+25.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2030 | −$1.08 | — | — |
| Sep 2030 | −$1.05 | — | — |
| Jun 2030 | −$1.06 | — | — |
| Mar 2030 | −$1.07 | — | — |
| Dec 2029 | −$1.04 | — | — |
| Sep 2029 | −$1.02 | — | — |
| Jun 2029 | −$0.99 | — | — |
| Mar 2029 | −$0.96 | — | — |
| Dec 2028 | −$0.86 | — | — |
| Sep 2028 | −$0.87 | — | — |
| Jun 2028 | −$0.87 | — | — |
| Mar 2028 | −$0.86 | — | — |
| Dec 2027 | −$0.68 | — | — |
| Sep 2027 | −$0.64 | — | — |
| Jun 2027 | −$0.61 | — | — |
| Mar 2027 | −$0.59 | — | — |
| Dec 2026 | −$0.50 | — | — |
| Nov 2026 | −$0.47 | — | — |
| Aug 2026 | −$0.43 | −$0.44 | −2.2% |
| May 2026 | −$0.31 | −$0.38 | −22.6% |
| Mar 2026 | −$21.59 | −$18.19 | +15.8% |
| Dec 2025 | −$0.11 | −$1.39 | −1,163.6% |
| Nov 2024 | |||
| Oct 2024 | −$0.11 | — | — |
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| May 2023 | |||
| Sep 2022 | |||
| Jan 2022 | |||
| Nov 2021 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2030 | −$1.08 | — | — | $2.7M | — | — | — |
| Sep 2030 | −$1.05 | — | — | $2.7M | — | — | — |
| Jun 2030 | −$1.06 | — | — | $2.7M | — | — | — |
| Mar 2030 | −$1.07 | — | — | $2.7M | — | — | — |
| Dec 2029 | −$1.04 | — | — | $2.7M | — | — | — |
| Sep 2029 | −$1.02 | — | — | $2.7M | — | — | — |
| Jun 2029 | −$0.99 | — | — | $2.7M | — | — | — |
| Mar 2029 | −$0.96 | — | — | $2.7M | — | — | — |
| Dec 2028 | −$0.86 | — | — | $2.1M | — | — | — |
| Sep 2028 | −$0.87 | — | — | $2.1M | — | — | — |
| Jun 2028 | −$0.87 | — | — | $2.1M | — | — | — |
| Mar 2028 | −$0.86 | — | — | $2.1M | — | — | — |
| Dec 2027 | −$0.68 | — | — | $1.4M | — | — | — |
| Sep 2027 | −$0.64 | — | — | $1.4M | — | — | — |
| Jun 2027 | −$0.61 | — | — | $1.4M | — | — | — |
| Mar 2027 | −$0.59 | — | — | $1.4M | — | — | — |
| Dec 2026 | −$0.50 | — | — | $5.7M | — | — | — |
| Nov 12, 2026 | −$0.47 | — | — | $3.8M | — | — | — |
| Aug 13, 2026 | −$0.43 | −$0.44 | −2.2% | $2.7M | $3.4M | +25.4% | +4.8% |
| May 11, 2026 | −$0.31 | −$0.38 | −22.6% | $1.9M | $3.2M | +67.2% | −1.8% |
| Mar 30, 2026 | −$21.59 | −$18.19 | +15.8% | $3.3M | $1.9M | −43.0% | +8.2% |
| Dec 3, 2025 | −$0.11 | −$1.39 | −1,163.6% | $12.4M | $4.6M | −62.9% | — |
| Nov 14, 2024 | |||||||
| Oct 8, 2024 | −$0.11 | — | — | $8.2M | — | — | — |
| May 13, 2024 | |||||||
| Feb 13, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Sep 6, 2023 | |||||||
| May 8, 2023 | |||||||
| Sep 12, 2022 | |||||||
| Jan 31, 2022 | |||||||
| Nov 1, 2021 |